Einat Brill Almon
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Einat Brill Almon
The proxy statement of Protalix BioTherapeutics, Inc. reports total compensation of $884,666 for Einat Brill Almon in fiscal 2020, including a base salary of $293,190.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Protalix BioTherapeutics, Inc. (PLX)
Proxy statement
Start not stated–2022-04-29
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Protalix BioTherapeutics, Inc. (PLX) | Senior Vice President, Chief Development Officer | $293,190 | $884,666 |
Recent activity
No call appearances or filed executive changes recorded yet.